## Case-Control Study Advantages for Rare Outcomes **Key Point:** Case-control studies are the **gold standard design for investigating rare outcomes** because they are time- and cost-efficient while still providing valid odds ratio estimates. ### Why Case-Control Excels for TB in HCWs TB among healthcare workers is a relatively **rare outcome** in the general HCW population. A cohort study would require: - Enrolling thousands of HCWs - Following them for years - Waiting for TB cases to develop - Enormous cost and time investment A case-control study instead: 1. **Identifies cases efficiently** — goes directly to HCWs already diagnosed with TB 2. **Selects matched controls** — from the same HCW population without TB 3. **Ascertains exposures** — retrospectively from both groups 4. **Calculates odds ratio** — which approximates relative risk when outcome is rare 5. **Completes quickly** — no follow-up period needed ### Odds Ratio vs Relative Risk **High-Yield:** In case-control studies: - **Odds Ratio (OR)** is calculated directly - When outcome is rare (< 10%), OR ≈ RR - When outcome is common (> 10%), OR > RR and overestimates risk $$OR = \frac{\text{Odds of exposure in cases}}{\text{Odds of exposure in controls}}$$ ### Comparison Table: Case-Control vs Cohort for Rare Outcomes | Feature | Case-Control | Cohort | |---------|--------------|--------| | **Efficiency for rare outcome** | Excellent — starts with cases | Poor — requires huge sample | | **Time to complete** | Months to 1–2 years | 5–10+ years | | **Cost** | Low to moderate | Very high | | **Effect measure** | Odds ratio | Relative risk | | **Causal inference strength** | Moderate (observational) | Stronger (temporal sequence) | **Clinical Pearl:** TB in HCWs is occupational and preventable — case-control design allows rapid identification of modifiable risk factors (PPE use, ventilation) without waiting years for new cases to develop in a cohort.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.